A Rapid Access to Novel and Known Benzimidazole Derivatives
acetate). IR spectra were recorded on an FT-IR Shima-
dzu-470 Spectrometer and the H NMR spectra were
5-Benzoyl-2-ethyl-benzimidazole 8
1H NMR
1
(CDC13, 400 MHz) δ: 10.70 (s, 1H), 8.06 (s, 1H), 7.78
(dd, J=8.1 Hz, 3H,), 7.58 (t, J=6.6 Hz, 2H), 7.47 (t,
J=7.6 Hz, 2H), 3.02 (q, J=7.6 Hz, 2H), 1.47 (t, J=7.6
Hz, 3H); 13C NMR (CDC13, 100 MHz) δ: 197.62,
159.75, 138.30, 132.21, 131.51, 129.97, 128.25, 124.86,
118.16, 114.27, 22.81, 12.32; IR (KBr) ν: 3300—2300,
1650, 1620, 1540, 1475, 1400, 1100, 960, 870,700; MS
(70 eV) m/z: 250.
2-Methyl-benzimidazole-5-yl-(phenyl)methanone
oxime 9 1H NMR (DMSO-d6, 400 MHz) δ: 12.30 (d,
J=11.2 Hz, 1H), 12.16 (s, 1H), 11.27 (d, J=20 Hz,
1H), 7.71—7.10 (m, 18H) 11.15 (s, 1H), 2.69 (s, 6H);
13C NMR (DMSO-d6, 100 MHz) δ: 156.38, 156.24,
153.00, 152.88, 138.74, 138.16, 134.82, 132.41, 130.69,
129.87, 129.41, 129.11, 128.82, 128.66, 128.52, 127.79,
126.69, 122.96, 120.85, 117.78, 110.82, 15.26, 15.14;
IR (KBr) ν: 3500—2300, 1620, 1540, 1450, 1320, 1120,
1000, 950, 890,780, 700; MS (70 eV) m/z: 251.
obtained on a Bruker-Instrument DPX-400 Avance 2
model. Mass spectra were recorded on a Shimadzu
Gc-MS QP 100 Ex spectrometer. All of the products
(except novel compounds) were characterized by com-
parison of their spectra and physical data, with those
reported in the literature.
Preparation of silica chloride 1
To an oven-dried (125 ℃, vacuum) sample of sil-
ica-gel 60 (10 g) in a round bottomed flask (250 mL)
equipped with a condenser and a drying tube, was added
thionyl chloride (40 mL) and the mixture in the pres-
ence of CaCl2 as a drying agent was refluxed for 48 h.
The resulting white-grayish powder was filtered and
stored in a tightly capped bottle.
Preparation of benzimidazole derivatives 4 using
silica chloride 1
2-Ethyl-benzimidazole-5-yl-(phenyl)methanone
oxime 10 1H NMR (DMSO-d6, 400 MHz) δ: 12.30 (d,
J=11.2 Hz, 1H), 12.16 (s, 1H), 11.27 (d, J=18.8 Hz,
1H), 11.15 (s, 1H), 7.71—7.03 (m, 18H), 2.82 (s, 4H),
1.30 (s, 6H); 13C NMR (DMSO-d6, 100 MHz) δ: 157.78,
156.38, 156.25, 143.70, 138.16, 134.95, 130.73, 129.00,
129.42, 129.09, 128.64, 128.51, 127.78, 126.89, 123.13,
120.63, 119.42, 118.12, 110.83, 22.50, 12.73, 12.59; IR
(KBr) ν: 3350, 3200—2300, 1620, 1540, 1450, 1320,
1120, 1000, 950, 890, 780, 700; MS (70 eV) m/z: 265.
A mixture of o-phenylenediamine 2 (1 mmol), or-
thoester 3 (1.1 mmol) and silica chloride 1 (3 mol%,
0.007 g) was stirred and heated at 80 ℃ in a preheated
oil bath for an appropriate time (Tables 3 and 4). After
completing the reaction as indicated by TLC (ethyl ace-
tate/n-hexan, 1∶2, V/V), the reaction mixture was dis-
solved in hot ethyl acetate and catalyst was separated by
simple filtration. The solvent was evaporated and the
crude product 4 was purified by recrystallization in
ethyl acetate.
Conclusions
Preparation of benzimidazole oxime derivatives 9, 10
A mixture of benzimidazole 7 or 8 (1 mmol),
hydroxylamine hydrochloride (5 mmol), sodium hy-
droxide (5 mmol) 5 mL of 95% ethyl alcohol, and 1 mL
of water is placed in a round-bottomed flask, then the
flask is connected to a reflux condenser, heated to boil-
ing, and refluxed for 5 h. After completion of the reac-
tion (TLC), the precipitate was filtered, thoroughly
washed with water, and dried to afford white solid as
pure products 9 and 10.
In this study, we presented a simple, powerful and
clean method for the synthesis of benzimidazole deriva-
tives (novel and known) by employing the silica chlo-
ride as a reusable solid acid catalyst under solvent-free
conditions. The simple experimental procedure, sol-
vent-free reaction conditions, utilization of an inexpen-
sive and readily available catalyst, short period of reac-
tion and good to excellent yields make this method a
valid contribution to the existing methodologies. Also,
the presence of transformable functionalities in the
novel products makes them potentially valuable from
the aspect of further synthetic manipulations.
Spectral data of novel compounds
5-Benzoyl-benzimidazole 6 1H NMR (CDC13,
400 MHz) δ: 8.22 (s, 1H), 8.18 (s, 1H), 7.84 (t, J=9.4
Hz, 3H), 7.72 (d, J=8.4 Hz, 1H), 7.60 (t, J=7.2 Hz
1H), 7.49 (t, J=8 Hz, 2H); 13C NMR (CDC13, 100
MHz) δ: 197.31, 157.80, 143.20, 138.11, 132.46, 132.34,
130.05, 128.32, 125.29, 115.12; IR (KBr) ν: 3250—
2300, 1650, 1615, 1450, 1100, 950, 870, 690; MS (70
eV) m/z: 222.
Acknowledgement
The authors gratefully acknowledge partial support
of this work by the Yasouj University Iran.
References
5-Benzoyl-2-methyl-benzimidazole 7 1H NMR
(CDC13, 400 MHz) δ: 8.04 (s, 1H), 7.81 (d, J=7.6 Hz,
2H), 7.75 (d, J=8 Hz, 1H), 7.57 (d, J=7.2 Hz, 2H),
7.47 (t, J=7.2 Hz, 2H), 2.67 (s, 3H); 13C NMR (CDC13,
100 MHz) δ: 197.51, 154.42, 138.28, 132.24, 131.64,
130.02, 128.27, 124.94, 15.17; IR (KBr) ν: 3200, 2350,
1665, 1620, 1510, 1320, 1020, 820, 720; MS (70 eV)
m/z: 236.
[1] Porcari, A. R.; Devivar, R. V.; Kucera, L. S.; Drach, J. C.; Town-
send, L. B. J. Med. Chem. 1998, 41, 1252.
[2] Roth, T.; Morningstar, M. L.; Boyer, P. L.; Hughes, S. H.; Buck-
heitjr, R. W.; Michejda, C. J. J. Med. Chem. 1997, 40, 4199.
[3] Migawa, M. T.; Girardet, J. L.; Walker, J. A.; Koszalka, G. W.;
Chamberlain, S. D.; Drach, J. C.; Townsend, L. B. J. Med. Chem.
1998, 41, 1242.
[4] Tamm, I. Science 1957, 126, 1235.
Chin. J. Chem. 2012, 30, 959—964
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
963